Phentermine And Topiramate Capsule, Extended Release
Product Images NDC 0480-3295

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Phentermine And Topiramate (NDC 0480-3295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of the active ingredient, phentermine hydrochloride, showing a phenyl ring, an amine group, and a hydrochloride component.*

FDA Label Image

1 (Image 10)

Label for Phentermine and Topiramate Extended-release Capsules 11.25 mg/69 mg by Teva Pharmaceuticals, Inc. The label includes dosage form as extended-release capsules, NDC 0480-2299-56, quantity of 30 capsules, and storage instructions. The cap color is described as light yellow opaque with printed text, and the label instructs pharmacists to dispense a Medication Guide. Manufactured in Bulgaria and for Teva Pharmaceuticals in New Jersey.*

FDA Label Image

1 (Image 11)

Label for Phentermine and Topiramate Extended-release Capsules, 15 mg/92 mg, by Teva Pharmaceuticals, Inc. The label states the capsule contents, description, storage instructions, and dosage guidance. It includes a barcode, manufacturer information for Balkanpharma Dupnitsa AD and Teva Pharmaceuticals, and indicates a package size of 30 capsules with a pharmacist dispensing note and Rx only status.*

FDA Label Image

1 (Image 2)

Chemical structure diagram showing the molecular formula of the active ingredient from the product data, phentermine and topiramate. The diagram depicts the arrangement of atoms and bonds characteristic of topiramate's chemical structure.*

FDA Label Image

1 (Image 3)

Two line graphs labeled Study 1 and Study 2 showing percent weight loss (LS Mean) over time in weeks for completers on study drug and ITT-LOCF populations. Each graph compares placebo, and various doses of phentermine and topiramate extended-release capsules: 3.75 mg/23 mg and 15 mg/92 mg in Study 1; 7.5 mg/46 mg and 15 mg/92 mg in Study 2. Weight loss increases over time with higher doses compared to placebo in both studies.*

FDA Label Image

1 (Image 4)

Phentermine and topiramate extended-release capsule imprinted with 'WPI 2196'. The capsule is elongated, with a white background and black imprint. This dosage form is manufactured by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 5)

Extended release capsule for phentermine and topiramate, imprinted with 'WPI 2195'. The capsule is white and oval-shaped. Labeler is Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 6)

Imprint on a white, capsule-shaped pill showing "WPI" on the top half and "229" on the bottom half. The capsule is associated with phentermine and topiramate extended-release formulations by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 7)

Capsule-shaped pill imprint showing 'WPI' on one side and '2194' on the other. This imprint corresponds to phentermine and topiramate extended-release capsules manufactured by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 8)

Phentermine and Topiramate extended-release capsules 3.75 mg/23 mg label by Teva Pharmaceuticals, Inc. Contains 30 capsules. The label includes dosage details, storage instructions, and manufacturer information. Capsules are described as white opaque/orange opaque with specific printing details. The label includes a barcode and a serialization coding area.*

FDA Label Image

1 (Image 9)

Label for Phentermine and Topiramate Extended-release Capsules, 7.5 mg/46 mg, manufactured by Teva Pharmaceuticals, Inc. The label indicates prescription use with 30 capsules per package. It includes capsule description, storage instructions (20° to 25°C), dosage instructions referencing package insert, and manufacturing details from Bulgaria and Parsippany, NJ. The packaging features barcodes, drug scheduling (CIV), and a pharmacist dispensing note.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.